.RESEARCH STUDY EMPHASIZE.16 Oct 2024.
In the NIAGARA hearing, the add-on of perioperative durvalumab to conventional treatment for muscle-invasive bladder cancer improved event-free and also in general survival, noting a brand new treatment alternative for this ailment.